ngµç×ÓÓÎÏ·

05

¿ÆÑÐÏ£Íû

ҩѧԺ£¨ÉîÛÚ£©¸ßÀíÇ®¿ÎÌâ×é¡°ÅÁ½ðÉ­²¡Ç±ÔÚÉúÎï±ê¼ÇÎïµÄÉúÎï³ÉÏñÓ«¹â̽Õ롱ÔÚChemical Society Reviews½ÒÏþ

¸å¼þȪԴ£º£º£ºÒ©Ñ§Ôº£¨ÉîÛÚ£© ÔĶÁÁ¿£º£º£º

ÅÁ½ðÉ­²¡(Parkinson's disease£¬PD), ÊÇÒ»ÖÖÖÐÊàÉñ¾­ÏµÍ³ÐÔÍËÐÐÐÔ¼²²¡£¬ÓÖ³ÆÕð²üÂéľ£¬¶à·¢ÓÚÍíÄêȺÌå¡£¡£PD×÷ΪµÚ¶þ´óÉñ¾­ÍËÐÐÐÔ¼²²¡£¬½ö´ÎÓÚ°¢¶û´Äº£Ä¬²¡¡£¡£¾Ýͳ¼Æ£¬ÎÒ¹úPD»¼ÕßÈËÊýÏÖÔÚ½ü300Íò£¬ÇÒÒÔÿÄê10ÍòµÄËÙÂÊÔÚµÝÔö¡£¡£Ëæ×ÅÎÒ¹úÉú³ÝÀÏÁ仯µÄ¼Ó¾ç£¬ÅÁ½ðÉ­²¡»¼ÕßµÄÊýÄ¿»¹ÔÚÒ»Ö±ÅÊÉý£¬¸øÉç»áºÍ¼ÒÍ¥´øÀ´ÁËÖØ´ó¾­¼ÃѹÁ¦ºÍ¼ç¸º£¬Í¬Ê±Ò²ÑÏÖØÍþвÈËÃñµÄÉúÃü¿µ½¡ºÍÉúÑÄÖÊÁ¿¡£¡£¿ÉÊÇ£¬ÏÖÔÚPDÐγɵÄÏêϸ»úÖÆÉв»ÍêÈ«Ã÷È·£¬PDÈÔºÜÄÑÖÎÓú¡£¡£ÕýÒòÔÆÔÆ£¬¿ª·¢ÐµĹ¤¾ß¸¨ÖúPDµÄÔçÆÚÕï¶ÏºÍÖÎÁÆÏԵúÜÊÇÖ÷Òª¡£¡£½üÄêÀ´£¬Ó«¹â̽Õë×÷ΪһÖÖ¹¦Ð§Ç¿Ê¢µÄÉúÎï³ÉÏñ¹¤¾ß£¬Í¨¹ý¶ÔÅÁ½ðÉ­²¡²¡ÀíÌØÕ÷µÄ¼ì²âºÍ¼à²â£¬ÓÐÍû×ÊÖúÏàʶÅÁ½ðÉ­²¡ÐγɵÄÏêϸ²¡ÀíÀú³Ì£¬¶ÔPDµÄÔçÆÚÕï¶ÏºÍÖÎÁƾßÓкÜÊÇÖ÷ÒªµÄ×÷Óᣡ£

¿ËÈÕ£¬ngµç×ÓÓÎϷҩѧԺ£¨ÉîÛÚ£©¸ßÀíÇ®¿ÎÌâ×é¼°ÆäÏàÖúµÄÑо¿ÍŶÓÖÜÈ«±¨µÀÁËÅÁ½ðÉ­²¡Ç±ÔÚÉúÎï±ê¼ÇÎïµÄÉúÎï³ÉÏñÓ«¹â̽ÕëÏà¹ØÏ£Íû£¬ÒÔ¡°Fluorescent probes for bioimaging of potential biomarkers in Parkinson¡¯s disease¡±ÎªÌâ½ÒÏþÔÚ¹ú¼Ê»¯Ñ§È¨Íþ¶¥¼âÔÓÖ¾Chemical Society Reviews£¨IF 42.846, DOI: 10.1039/d0cs00115e£©ÉÏ¡£¡£

Ê×Ò³|ngµç×ÓÓÎÏ·Öйú¼¯ÍŹٷ½ÍøÕ¾

ͼ1. ÅÁ½ðÉ­²¡Ç±ÔÚÉúÎï±ê¼ÇÎï¼°ÆäÉúÎï³ÉÏñÓ«¹â̽Õë

PDÖ÷ÒªÌåÏÖΪÖÐÄÔºÚÖʶà°Í°·ÄÜÉñ¾­Ôª¹¦Ð§È±Ê§£¬ÆäÖ÷Òª²¡ÀíÌØÕ÷°üÀ¨¦Á-Í»³öºËÂѰף¨a-Synuclein£¬a-syn£©Òì³£»£»£»ýÀÛȺ¼¯¡¢¡¢½ðÊôÀë×ÓÆ½ºâʧµ÷¡¢¡¢Ñõ»¯Ó¦¼¤¡¢¡¢ÏßÁ£Ì幦ЧÕϰ­ºÍÉñ¾­µÝÖÊȱ·¦µÈ¡£¡£±¾ÎÄÖÜÈ«×ܽáºÍ±¨µÀÁËÓ«¹â̽ÕëµÄÉè¼Æ¡¢¡¢·¢¹â»úÀí¼°ÆäÔÚÖÖÖÖPDÉúÎï±ê¼ÇÎï¼ì²âÖеÄÓ¦Óᣡ£Ê×ÏÈ£¬±¾ÎĽéÉÜÁËÏÖÔÚPDÉúÎïÓ«¹â³ÉÏñµÄÏÖ×´£¬²¢×ܽáÆÊÎöÁËPDDZÔڰбêµÄÓ«¹â̽ÕëµÄ×ܵÄÉè¼ÆÕ½ÂÔ£»£»£»È»ºó£¬ÒÔa-syn£¬µ¥°·Ñõ»¯Ã¸B£¬¶à°Í°·Ïà¹Øµ÷ÀíÒò×Ó£¬½ðÊôÀë×Ó£¬»îÐÔÑõ£¬»îÐÔÁòµÈDZÔڰбê·ÖÀà½éÉÜÁËÕâЩ±ê¼ÇÎïµÄÓ«¹â̽ÕëµÄÉè¼ÆÔ­Àí£¬³ÉÏñ»úÀí¡¢¡¢ÉúÎïÓ¦ÓùæÄ£ÒÔ¼°±£´æµÄȱ·¦£¬ÕâЩ̽Õë·Ö×ÓÀàÐͰüÀ¨£º£º£ºÈº¼¯ÓÕµ¼Ð¡·Ö×Ó£¬¹ý¶É½ðÊô¸´ºÏÎ½üºìÍâÓ«¹â·Ö×Ó£¬Ë«¹â×ÓС·Ö×ÓÒÔ¼°»ùÓÚ·´Ó³Ð͵ĶàëĺÍС·Ö×ӵȡ£¡£×îºó£¬ÎÄÕÂÌá³öÁËPDÉúÎï³ÉÏñµÄ̽Õ뿪չÐèÒª¶àѧ¿Æ½»Ö¯¡¢¡¢¶àÕ½ÂÔÁªºÏÓ¦Óã¬ÈçÒ©Îﻯѧ£¬ÉúÎﻯѧ£¬ÖÊÁÏ»¯Ñ§µÈѧ¿Æ½»Ö¯ÒÔ¼°Èº¼¯ÓÕµ¼·¢¹âÖÊÁÏ¡¢¡¢½üºìÍâ̽Õë¡¢¡¢Î¢ÕóÁк͡°Ò»ÖéÒ»»¯ºÏÎµÄ¸ßͨÁ¿É¸Ñ¡¡¢¡¢DNA±àÂë¿âµÈ¶àÕ½ÂÔµÄÁªºÏÓ¦Ó㬽ø¶øÎªÒÔºóÉè¼Æ³öÌØÒìÐÔ¸üºÃ¡¢¡¢Ñ¸Ëٶȸü¸ßµÄPDÓ«¹â̽ÕëÓÃÓÚPD¼²²¡µÄÔçÆÚÕï¶Ï¡¢¡¢·¢²¡»úÖÆµÄ̽ÌÖÒÔ¼°Ñз¢¸üºÃµÄÓÃÓÚPD²¡È˵ÄÖÎÁÆÒ©ÎïÌṩÓмÛÖµµÄÐÅÏ¢¡£¡£

Ê×Ò³|ngµç×ÓÓÎÏ·Öйú¼¯ÍŹٷ½ÍøÕ¾

ͼ2. PDÓ«¹â̽ÕëµÄÀíÐÔÉè¼ÆÕ½ÂÔ

ÔÚÕâÏîÊÂÇéÖУ¬ngµç×ÓÓÎϷҩѧԺ£¨ÉîÛÚ£©¸ßÀíÇ®¸±½ÌÊÚ¡¢¡¢²©Ê¿ÉúÍôΰ¡¢¡¢Ë¶Ê¿ÉúÍõè¯ÎªÎÄÕµÄÅäºÏµÚÒ»×÷Õߣ¬ngµç×ÓÓÎϷҩѧԺ£¨ÉîÛÚ£©¸ßÀíÇ®¸±½ÌÊÚ¡¢¡¢Ð¤Ææ²Å¸±Ñо¿Ô±ºÍÐÂ¼ÓÆÂ¹úÁ¢´óѧ»¯Ñ§ÏµÒ¦ÉÙÇÕ½ÌÊÚΪÎÄÕµÄͨѶ×÷Õß¡£¡£±ðµÄ£¬ngµç×ÓÓÎϷҩѧԺ£¨ÉîÛÚ£©µÄÑî·Ò²©Ê¿¡¢¡¢Ë¶Ê¿ÉúлÁõÐÒ¡¢¡¢ngµç×ÓÓÎÏ·ËïÒÝÏɼÍÄîÒ½ÔºÉò¾ý½ÌÊÚ¡¢¡¢ÐÂÎ÷À¼°Â¿ËÀ¼´óѧMargaret A. BrimbleԺʿҲ¼ÓÈëÁËÕâÏîÊÂÇé²¢¸øÓèÁËÐí¶à×ÊÖúºÍÖ§³Ö¡£¡£

´ËÏîÊÂÇéÊܵ½Á˹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ð£¬¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ð-¹ã¶«Ê¡ÁªºÏ»ù½ð¼¯³ÉÏîÄ¿£¬¹ã¶«Ê¡¿Æ¼¼ÌüÖØµãÑз¢ÍýÏ룬ÉîÛÚÊпƴ´Î¯×ÔÓÉ̽Ë÷ºÍÖÐÑë¸ßУngµç×ÓÓÎÏ·ÇàÄêÎ÷ϯÅàÓýÏîÄ¿£¬¹ã¶«Ê¡¡°Ö齭ѧÕß¡±ºÍÐÂ¼ÓÆÂ¹ú¼ÒÑо¿»ù½ð»áµÈÏîÄ¿µÄ×ÊÖú¡£¡£

ÂÛÎÄÁ´½Ó: https://pubs.rsc.org/en/content/articlelanding/2021/CS/D0CS00115E#!divAbstract

¡¾ÍøÕ¾µØÍ¼¡¿